|
|
| | Glycine, N-[(2,3,4,5-tetrahydro-2,4-dioxo-1H-1,5-benzodiazepin-7-yl)sulfonyl]- Basic information |
| Product Name: | Glycine, N-[(2,3,4,5-tetrahydro-2,4-dioxo-1H-1,5-benzodiazepin-7-yl)sulfonyl]- | | Synonyms: | Glycine, N-[(2,3,4,5-tetrahydro-2,4-dioxo-1H-1,5-benzodiazepin-7-yl)sulfonyl]-;((2,4-Dioxo-2,3,4,5-tetrahydro-1h-benzo[b][1,4]diazepin-7-yl)sulfonyl)glycine | | CAS: | 923718-70-1 | | MF: | C11H11N3O6S | | MW: | 313.29 | | EINECS: | | | Product Categories: | | | Mol File: | 923718-70-1.mol | ![Glycine, N-[(2,3,4,5-tetrahydro-2,4-dioxo-1H-1,5-benzodiazepin-7-yl)sulfonyl]- Structure](CAS/20210111/GIF/923718-70-1.gif) |
| | Glycine, N-[(2,3,4,5-tetrahydro-2,4-dioxo-1H-1,5-benzodiazepin-7-yl)sulfonyl]- Chemical Properties |
| density | 1.560±0.06 g/cm3(Predicted) | | pka | 3.27±0.10(Predicted) |
| | Glycine, N-[(2,3,4,5-tetrahydro-2,4-dioxo-1H-1,5-benzodiazepin-7-yl)sulfonyl]- Usage And Synthesis |
| | Glycine, N-[(2,3,4,5-tetrahydro-2,4-dioxo-1H-1,5-benzodiazepin-7-yl)sulfonyl]- Preparation Products And Raw materials |
|